Now, MedStar Health is undertaking two phase III randomized clinical trials to understand the potential benefits of retatrutide beyond weight loss: TRANSCEND-T2D-2 includes adult participants who take metformin alone or with an SGLT2 inhibitor for Type 2 diabetes
You won't know you've been injecting 2500mcg instead of 250mcg until the data doesn't match prior literature
Ghent University Tang WW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL (2013) Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Patients with higher baseline weight, insulin resistance, or certain comorbidities may see faster initial losses, though sustained progress depends on maintaining lifestyle changes alongside medication